The latest research showed that FOXD3-AS1 targets the miR-127-3p/FJX1 axis in melanoma progression (120) and FJX1 facilitates cell proliferation and motility in colon adenocarcinoma by inhibiting miR‐1249 (121, 122). Here, FJX1 is linked to colon adenocarcinoma.